Not getting enough of the deeper stages of sleep raises the risk of brain deterioration associated with Alzheimer’s disease, ...

Having already been hailed for their ability to aid weight loss and treat diabetes, GLP-1 drugs like Ozempic and Mounjaro ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

AXS-05 was well-tolerated and significantly delayed the time to agitation relapse compared with placebo in patients with ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.

Lower levels of "bad" LDL cholesterol could mean a lower risk of dementia and Alzheimer's disease, a new study says.

The explanation of Alzheimer's, given the span of the disease, could become more of an ongoing process for the child rather ...

Albers and colleagues are interested in whether olfactory dysfunction — the sometimes-subtle loss of sense of smell — can ...

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...

The findings suggest that the shingles virus might play a role in causing at least a subset of dementia cases, Geldsetzer ...